![Glyn Baker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Glyn Baker
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Glyn Baker via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Nereid Therapeutics, Inc.
![]() Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Mirror Biologics Inc
![]() Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member | |
Prime Movers Lab LLC
![]() Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Consultant / Advisor | |
ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Millennium Predictive Medicine, Inc. | Founder | ||
Bessemer Venture Partners LP
![]() Bessemer Venture Partners LP Investment ManagersFinance Bessemer Venture Partners LP seeks investment opportunities in companies primarily located in the US. The fund focuses on companies with a strong business model, experienced management teams and growth potential. It targets companies operating across a broad range of sectors such as healthcare, information systems, telecommunications, and retailing. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Consultant / Advisor | |
Excision BioTherapeutics, Inc.
![]() Excision BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Excision BioTherapeutics, Inc. develops gene editing therapeutics for the treatment of life-threatening disease caused by viral infections. The firm focuses on Human Immunodeficiency Virus -1 therapeutics, JC Virus and Progressive Multifocal Leukoencephalopathy, Hepatitis B virus therapeutics, and CRISPR vaccinations?. The company was founded by David Rowe, Kamel Khalili, Thomas Malcolm, and Rob Simmons in 2015 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
VERASTEM, INC. | Biotechnology | Chairman | |
Metamark Genetics, Inc.
![]() Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Founder | |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amherst College | College/University | Undergraduate Degree | |
INSTIL BIO, INC. | Biotechnology | Director of Finance/CFO |
Statistiques
Internationale
Etats-Unis | 25 |
Sectorielle
Health Technology | 17 |
Consumer Services | 3 |
Finance | 3 |
Commercial Services | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 12 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Consultant / Advisor | 2 |
Relations les plus connectées
Insiders | |
---|---|
Michael Kauffman | 24 |
Alex Hughes | 2 |
- Bourse
- Insiders
- Glyn Baker
- Connexions Sociétés